Artificial Pancreas Device Systems Market Size, Share, Trends, Growth Outlook

Artificial Pancreas Device Systems Market is estimated to increase at a growth rate of 18.5% CAGR over the forecast period from 2024 to 2030.

The Artificial Pancreas Device Systems Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Device Type, Threshold Suspended Device System, Control To Range (CTR) System, Control to Target (CTT) System), By End-User (Hospitals and Clinics, Others).

An Introduction to Artificial Pancreas Device Systems Market in 2024

The Artificial Pancreas Device Systems Market in 2024 is witnessing rapid growth, driven by the increasing prevalence of diabetes, rising demand for automated insulin delivery solutions, and advancements in closed-loop systems to optimize glucose control, reduce hypoglycemia, and improve diabetes management outcomes. Diabetes mellitus represents a significant global health challenge, necessitating continuous monitoring of blood glucose levels and precise insulin dosing to maintain glycemic stability and prevent long-term complications. With advancements in glucose sensing technology, insulin infusion pumps, and control algorithms, the market offers a variety of artificial pancreas device systems (APDS), including hybrid closed-loop systems and fully automated closed-loop systems, designed to mimic the physiological function of the pancreas and provide personalized insulin delivery based on real-time glucose data. Moreover, the integration of diabetes education programs, remote monitoring platforms, and telemedicine services further enhances patient engagement, treatment adherence, and diabetes self-management, driving market expansion and supporting the adoption of innovative APDS technologies in clinical practice and home care settings.

Artificial Pancreas Device Systems Market Trend: Integration of Artificial Intelligence and Machine Learning

A prominent trend in the Artificial Pancreas Device Systems market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into these systems. AI and ML algorithms are being utilized to optimize glucose monitoring, insulin delivery, and predictive modeling, enabling more precise and personalized management of diabetes. These advanced capabilities enhance the efficiency, accuracy, and safety of artificial pancreas systems, leading to improved glycemic control and better outcomes for patients with diabetes.

Artificial Pancreas Device Systems Market Driver: Growing Prevalence of Diabetes and Demand for Automated Glucose Management

The rising prevalence of diabetes worldwide, coupled with the increasing demand for automated glucose management solutions, serves as a significant driver for the Artificial Pancreas Device Systems market. With the global diabetes epidemic escalating, there is a growing need for innovative technologies that can automate and simplify diabetes management while minimizing the risk of complications. Artificial pancreas systems offer a comprehensive approach to glucose control by continuously monitoring blood sugar levels and adjusting insulin delivery in real-time, thereby providing patients with greater freedom and improved quality of life.

Artificial Pancreas Device Systems Market Opportunity: Expansion of Closed-Loop Systems and Wearable Devices

An opportunity in the Artificial Pancreas Device Systems market lies in the expansion of closed-loop systems and wearable devices for diabetes management. As technological advancements continue to progress, there is potential for the development of more compact and user-friendly artificial pancreas systems that integrate seamlessly into patients' daily lives. By focusing on miniaturization, portability, and enhanced connectivity, manufacturers can cater to the growing demand for wearable solutions that offer continuous glucose monitoring and automated insulin delivery, thereby empowering individuals with diabetes to better manage their condition with greater convenience and flexibility.

Artificial Pancreas Device Systems Market Segmentation

By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Artificial Pancreas Device Systems Market Companies

Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc

 

 

Reasons to Buy the Artificial Pancreas Device Systems Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Artificial Pancreas Device Systems Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Artificial Pancreas Device Systems Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Artificial Pancreas Device Systems Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Artificial Pancreas Device Systems Market Size Outlook, $ Million, 2021 to 2030
3.2 Artificial Pancreas Device Systems Market Outlook by Type, $ Million, 2021 to 2030
3.3 Artificial Pancreas Device Systems Market Outlook by Product, $ Million, 2021 to 2030
3.4 Artificial Pancreas Device Systems Market Outlook by Application, $ Million, 2021 to 2030
3.5 Artificial Pancreas Device Systems Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Artificial Pancreas Device Systems Market Industry
4.2 Key Market Trends in Artificial Pancreas Device Systems Market Industry
4.3 Potential Opportunities in Artificial Pancreas Device Systems Market Industry
4.4 Key Challenges in Artificial Pancreas Device Systems Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Artificial Pancreas Device Systems Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Artificial Pancreas Device Systems Market Outlook By Segments
7.1 Artificial Pancreas Device Systems Market Outlook by Segments
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

8 North America Artificial Pancreas Device Systems Market Analysis And Outlook To 2030
8.1 Introduction to North America Artificial Pancreas Device Systems Markets in 2024
8.2 North America Artificial Pancreas Device Systems Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Artificial Pancreas Device Systems Market size Outlook by Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

9 Europe Artificial Pancreas Device Systems Market Analysis And Outlook To 2030
9.1 Introduction to Europe Artificial Pancreas Device Systems Markets in 2024
9.2 Europe Artificial Pancreas Device Systems Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Artificial Pancreas Device Systems Market Size Outlook By Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

10 Asia Pacific Artificial Pancreas Device Systems Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Artificial Pancreas Device Systems Markets in 2024
10.2 Asia Pacific Artificial Pancreas Device Systems Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Artificial Pancreas Device Systems Market size Outlook by Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

11 South America Artificial Pancreas Device Systems Market Analysis And Outlook To 2030
11.1 Introduction to South America Artificial Pancreas Device Systems Markets in 2024
11.2 South America Artificial Pancreas Device Systems Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Artificial Pancreas Device Systems Market size Outlook by Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

12 Middle East And Africa Artificial Pancreas Device Systems Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Artificial Pancreas Device Systems Markets in 2024
12.2 Middle East and Africa Artificial Pancreas Device Systems Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Artificial Pancreas Device Systems Market size Outlook by Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others